• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER MUSCULAR VSD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER MUSCULAR VSD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-VSD-MUSC-010
Device Problem Human-Device Interface Problem (2949)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Event Description
The article, "transcatheter closure of residual and iatrogenic ventricular septal defects: tertiary center experience and outcome" was reviewed.This research article presents a case on a (b)(6) female patient who underwent previous transcatheter closure of a ventricular septal defect (vsd) with 10mm amplatzer muscular vsd occluder at the age of 14.3 years later, a residual peri-membranous vsd proximal to the previous device measuring 4 mm was visualized on transthoracic echocardiogram (tte) and by left ventriculography.The patient underwent another transcatheter procedure to close the residual vsd.A 4mm amplatzer duct occluder ii was successfully implanted with no residual shunt shown on angiogram and tte.No additional information was provided.The article concluded that transcatheter closure of post-operative and post-intervention residual/iatrogenic vsds represents a safe, feasible, and effective therapeutic approach.The primary and correspondence author of the article is (b)(6).
 
Manufacturer Narrative
As reported in a research article, three years after amplatzer vsd occluder implant, a patient has a residual peri-membranous vsd proximal to the device and an amplatzer duct occluder ii was implanted off-label.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER MUSCULAR VSD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
MDR Report Key12658178
MDR Text Key281920812
Report Number2135147-2021-00415
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P040040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial
Report Date 10/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-VSD-MUSC-010
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age17 YR
-
-